Strategic Overview

MARTI TB Diag develops MARTI, a blood-based biomarker test for TB screening.

Innovation Portfolio

MARTI
Category: SCREENING Stage: Late Stage

Multiplex host-response biomarker panel for TB screening using fingerstick blood. Designed for decentralized primary care settings.

Biomarker Blood

Key Milestones

MARTI blood-based biomarker test
Primary-level screening capability
30-minute turnaround time